Sign up to save your podcasts
Or
Share Edoxaban vs low molecular weight heparin in cancer-related VTE; New treatment for cystic fibrosis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Edoxaban vs low molecular weight heparin in cancer-related VTE; New treatment for cystic fibrosis
Today’s UpToDate Talk episode features discussions related to three papers published in the New England Journal of Medicine. Dr. Jess Mandel discusses anticoagulation options for cancer-associated venous thromboembolism, and Dr. George Mallory discusses two studies of tezacaftor-ivacaftor in patients with cystic fibrosis. Segment two begins at 11:32. Dr. Helen Hollingsworth hosts.
View all episodes
By UpToDate
4.3
121121 ratings
Today’s UpToDate Talk episode features discussions related to three papers published in the New England Journal of Medicine. Dr. Jess Mandel discusses anticoagulation options for cancer-associated venous thromboembolism, and Dr. George Mallory discusses two studies of tezacaftor-ivacaftor in patients with cystic fibrosis. Segment two begins at 11:32. Dr. Helen Hollingsworth hosts.
More shows like UpToDate Talk
View all
NEJM This Week
318 Listeners
The Curbsiders Internal Medicine Podcast
3,338 Listeners